?
Can we develop mutation-specific therapies?
active
open question
Created: 2026-04-25T20:29:46
By: backfill_open_questions
Quality:
50%
✓ SciDEX
ID: open_question-3c1aa4e9-3552-4b60-a600-ff
Open Question
open
Wiki: genes-scna1a
Can we develop mutation-specific therapies?
Importance Elo
1500
Field Rank
Rank #1485 in genes
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page genes-scna1a
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
Targeted APOE4-to-APOE3 Base Editing Therapy
candidate answer · hypothesis · 82%
CRISPR Gene Correction Approaches for CBS/PSP
partial answer for · experiment · 70%
Clinical outcome analysis based on IDH mutation status
partial answer for · experiment · 65%
LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Never Develop PD
discriminating experiment · experiment · 62%
TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism and Therapeutic Exploitation
partial answer for · experiment · 60%
Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
partial answer for · experiment · 58%
FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutation Carriers Develop FXTAS
partial answer for · experiment · 58%
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Therapy
partial answer for · experiment · 55%
AAV-LRRK2 Gene Therapy IND-Enabling Study Design
partial answer for · experiment · 52%
AAV-LRRK2 IND-Enabling Study Design
partial answer for · experiment · 52%
Multi-Modal CRISPR Platform for Simultaneous Editing and Monitoring
bears on question · hypothesis · 40%
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
Multi-Modal CRISPR Platform for Simultaneous Editing and Monitoring
hypothesis | bears_on_question
Targeted APOE4-to-APOE3 Base Editing Therapy
hypothesis | candidate_answer
Related Entities
▸Metadata
| status | open |
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:29:46.833135'} |
| field_tag | genes |
| source_id | genes-scna1a |
| sub_field | scna1a |
| source_kind | wiki |
| question_hash | a8e8390b14107accb0973886ad430912f5f9bc846c01058d87c1aa25508225d2 |
| question_text | Can we develop mutation-specific therapies? |
| importance_elo | 1500 |
| _schema_version | 1 |
| evidence_summary | Extracted from wiki page genes-scna1a |
| evidence_xref_at | 2026-04-27T11:51:20.623670+00:00 |
| tractability_score | 0.5 |
| potential_impact_score | 0.5 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
12
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.